Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2900
0.00 (0.00%)
Apr 2, 2026, 4:08 PM HKT

HKG:8189 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-27.8-20.16-27.45-42.26
Depreciation & Amortization
9.1311.6315.059.51
Other Amortization
--0.34-
Loss (Gain) From Sale of Assets
0.280.20.05-0.15
Asset Writedown & Restructuring Costs
7.16--22.26
Loss (Gain) From Sale of Investments
-0.94-5.96-2.34
Loss (Gain) on Equity Investments
----1
Provision & Write-off of Bad Debts
9.999.484.8911.74
Other Operating Activities
-9.35-5.744.440.88
Change in Accounts Receivable
-12.0313.31-2.070.07
Change in Inventory
11.9-16.551.2216.42
Change in Accounts Payable
-7.18-5.41-8.81-14.24
Change in Unearned Revenue
-0.9915.215.85-11.26
Change in Other Net Operating Assets
-9.23-10.472.083.67
Operating Cash Flow
-26.27-13.15-12.82-6.68
Capital Expenditures
-2.56-2.47-8.8-27.6
Sale of Property, Plant & Equipment
2.940-0.71
Cash Acquisitions
---10.45-
Divestitures
-0.06-4.07-
Investment in Securities
-1.751.4924.05
Other Investing Activities
-37.570.250.76-5.67
Investing Cash Flow
-37.24-0.47-12.93-8.51
Short-Term Debt Issued
-5.160.1-
Long-Term Debt Issued
14790.9956.1247.6
Total Debt Issued
14796.1556.2247.6
Short-Term Debt Repaid
--0.1--
Long-Term Debt Repaid
-64.05-83.32-50.05-19.5
Total Debt Repaid
-64.05-83.42-50.05-19.5
Net Debt Issued (Repaid)
82.9512.736.1728.1
Financing Cash Flow
82.9512.736.1728.1
Net Cash Flow
19.44-0.89-19.5812.91
Free Cash Flow
-28.83-15.62-21.62-34.28
Free Cash Flow Margin
-7.48%-3.92%-5.36%-7.20%
Free Cash Flow Per Share
-0.01-0.01-0.01-0.02
Cash Interest Paid
4.586.086.45.47
Cash Income Tax Paid
0-0.04-1.49-0.06
Levered Free Cash Flow
-48.97-4.2-13.24-25.89
Unlevered Free Cash Flow
-46.1-0.97-9.24-22.48
Change in Working Capital
-17.53-3.91-1.73-5.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.